CAPOOR, Manu, Jan LOCHMAN, Andrew MCDOWELL, Jonathan E. SCHMITZ, Martin SOLANSKÝ, Martina ZAPLETALOVÁ, Todd F. ALAMIN, Michael F. COSCIA, Steven R. GARFIN, Radim JANČÁLEK, Filip RŮŽIČKA, Nick A. SHAMIE, Martin SMRČKA, Jeffrey C. WANG, Christof BIRKENMAIER and Ondřej SLABÝ. Intervertebral disc penetration by antibiotics used prophylactically in spinal surgery: implications for the current standards and treatment of disc infections. European Spine Journal. NEW YORK: Springer, 2019, vol. 28, No 4, p. 783-791. ISSN 0940-6719. Available from: https://dx.doi.org/10.1007/s00586-018-5838-z.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Intervertebral disc penetration by antibiotics used prophylactically in spinal surgery: implications for the current standards and treatment of disc infections
Authors CAPOOR, Manu (840 United States of America, belonging to the institution), Jan LOCHMAN (203 Czech Republic, belonging to the institution), Andrew MCDOWELL (826 United Kingdom of Great Britain and Northern Ireland), Jonathan E. SCHMITZ (840 United States of America), Martin SOLANSKÝ (203 Czech Republic, belonging to the institution), Martina ZAPLETALOVÁ (203 Czech Republic, belonging to the institution), Todd F. ALAMIN (840 United States of America), Michael F. COSCIA (840 United States of America), Steven R. GARFIN (840 United States of America), Radim JANČÁLEK (203 Czech Republic, belonging to the institution), Filip RŮŽIČKA (203 Czech Republic, belonging to the institution), Nick A. SHAMIE (840 United States of America), Martin SMRČKA (203 Czech Republic, belonging to the institution), Jeffrey C. WANG (840 United States of America), Christof BIRKENMAIER (276 Germany) and Ondřej SLABÝ (203 Czech Republic, guarantor, belonging to the institution).
Edition European Spine Journal, NEW YORK, Springer, 2019, 0940-6719.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30103 Neurosciences
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.458
RIV identification code RIV/00216224:14740/19:00109487
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1007/s00586-018-5838-z
UT WoS 000463673200018
Keywords in English Propionibacterium acnes; Cutibacterium acnes; Degenerative disc disease; Biofilm; Cefazolin; Clindamycin; Vancomycin; Surgical prophylaxis
Tags 14110113, 14110131, 14110224, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 3/3/2020 16:50.
Abstract
PurposeThe presence of Propionibacterium acnes in a substantial component of resected disc specimens obtained from patients undergoing discectomy or microdiscectomy has led to the suggestion that this prominent human skin and oral commensal may exacerbate the pathology of degenerative disc disease. This hypothesis, therefore, raises the exciting possibility that antibiotics could play an important role in treating this debilitating condition. To date, however, little information about antibiotic penetration into the intervertebral disc is available. MethodsIntervertebral disc tissue obtained from 54 microdiscectomy patients given prophylactic cefazolin (n=25), clindamycin (n=17) or vancomycin (n=12) was assayed by high-performance liquid chromatography, with cefaclor as an internal standard, to determine the concentration of antibiotic penetrating into the disc tissue.ResultsIntervertebral disc tissues from patients receiving the positively charged antibiotic clindamycin contained a significantly greater percentage of the antibacterial dose than the tissue from patients receiving negatively charged cefazolin (P<0.0001) and vancomycin, which has a slight positive charge (P<0.0001).ConclusionPositively charged antibiotics appear more appropriate for future studies investigating potential options for the treatment of low-virulence disc infections. [GRAPHICS]
Links
MUNI/A/1189/2018, interní kód MUName: Původci nozokomiálních nákaz a možnosti jejich diagnostiky a terapie (Acronym: PNNMDT)
Investor: Masaryk University, Category A
PrintDisplayed: 20/7/2024 02:21